Competing Causes of Death for Women With Breast Cancer and Change Over Time From 1975 to 2003

Abstract

This study was to determine whether the proportion of death due to breast cancer changed over time in different cohorts of women diagnosed with breast cancer. We identified 316,149 women with breast cancer at age 20 or older during 1975-2003 from the Surveillance, Epidemiology, and End Results 9 tumor registries in the United States. Logistic regression models were used to assess the effects of time period on the likelihood of dying because of breast cancer as underlying cause of death, adjusting for other factors. Overall, underlying cause of death was 52.8% due to breast cancer, 17.8% due to heart disease, and 4.9% due to stroke. Percentage of death due to breast cancer did not change significantly from 1975 to 2003 in those who died <12 months after diagnosis, but decreased significantly in women who died between 1 and 15 years. Risk of death due to breast cancer in women diagnosed during 1995-1998 was significantly lower than those in [1975][1976][1977][1978][1979] (odds ratio = 0.79, 95% confidence interval = 0.70 -0.89), after adjusting for age, race, ethnicity, and tumor stage. Percentage of death due to breast cancer decreased significantly with age from 87.5% in women <40% to 30.7% in those 80 or older, which was not significantly affected by year of diagnosis. Proportion of death due to breast cancer increased with advanced tumor stage and was similar in various racial/ethnic groups of population. The findings demonstrated that the impact of breast cancer on overall death was reduced after 1 year of diagnosis, but suggested the need for continued cancer surveillance.Keywords breast cancer; cause of death; women; SEER; tumor registry; temporal trend Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death in women. 1-4 According to the American Cancer Society data, it was estimated that 212,920 women will be diagnosed with and 40,970 women will die of breast cancer in 2006. 3 During the past decade, mortality for patients with breast cancer decreased significantly, 1 largely because of early detection or screening for breast cancer and advances in medical care and treatments. 5-17 As a result, many patients with breast cancer can live much longer than ever before, and many of these women will die of causes other than breast cancer when they are getting older. However, there is little information on how the main underlying causes of death changed over time during the past several decades for women with breast cancer, although NIH-PA Author ManuscriptNIH-PA Author Manuscript NIH-PA Author Manuscript several studies have examined competing causes of death for women with breast cancer and found that other causes of death increased with age. 18-22 Schairer et al found that the probability of death from breast cancer relative to the probability of death from other causes declined with age. 22 However, it is unknown if the proportion of death from breast cancer relative to other causes changed over time in different cohorts of women diagnosed with breast cancer from 19...

Development and Validation of Endovascular Chemotherapy Filter Device for Removing High-Dose Doxorubicin: Preclinical Study

“…In the US there are now over 13 million cancer survivors. For breast cancer survivors alone, it is estimated that $800 million will be spent annually providing cardiovascular care [39,40]. Our proposed technique of CF may be translated into clinical setting for managing patients like these.…”

Association between age and survival in a cohort of Brazilian patients with operable breast cancer

“…One should note that the risk of dying from diseases other than breast cancer increases with time since diagnosis 38,39 , especially after ten years. Since the median follow-up time in our study was much shorter, we already expected a larger proportion of deaths (82% of total of deaths) due to breast cancer compared to other studies.…”

Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer

“…Death rates from breast cancer have decreased steadily since 1990 due to improved rates of early detection and treatment advances [2]. Recent improvements in treatment include therapies that specifically target estrogen metabolism or Her2/neu receptor-induced signaling.…”